Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Study will evaluate TSO in pediatric patients with autism spectrum disorder

April 14, 2014

Lytix Biopharma forms Pharmasum Therapeutics to focus on dementia

April 14, 2014

Impax resubmits NDA for IPX-066

April 14, 2014

Pfizer discloses novel Abeta production inhibitors

April 14, 2014

Pfizer returns Aversion product rights to Acura Pharmaceuticals

April 11, 2014

Neurolixis receives grant to test NLX-101 in animal models of Rett syndrome

April 11, 2014

Tetra Discovery collaborates with Broad Institute's Stanley Center on schizophrenia

April 11, 2014

Scientists at Roche design novel agents for CNS disorders

April 11, 2014

PRX-002 enters phase I for Parkinson's disease

April 11, 2014

World Parkinson's Day News: recent pathological insights and repurposing efforts

April 11, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.